You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thymic Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thymic Carcinoma Trial in Shanghai (Envolizumab combined with radiotherapy)

Recruiting
  • Thymic Carcinoma
  • Envolizumab combined with radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 3, 2023

Molecular Analysis and Treatment Options of Thymic Malignancies

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Shanghai, Shanghai, China
    Xiaomin Niu
Dec 28, 2022

Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer Trial run by the NCI (PT-112)

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Thymoma, Thymic Cancer Trial in Houston (Pembrolizumab)

Recruiting
  • Stage III Thymoma AJCC v8
  • +6 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 11, 2022

Thymic Carcinoma Trial in Columbus (other, biological, drug)

Recruiting
  • Thymic Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 27, 2022

YY-20394 in Patients With Relapsed/Refractory Thymic Cancer

Not yet recruiting
  • Effectiveness，Safety，Thymic Cancer
  • (no location specified)
Jul 20, 2021

Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

Not yet recruiting
  • Untreated Advanced or Recurrent Thymic Carcinomas
  • Chuo, Tokyo, Japan
    National Cancer Center Hospital
Apr 16, 2023

Thymic Malignancies, Pleural Metastases Trial in United States (Intensity-Modulated Pleural Radiation Therapy (IMPRINT))

Recruiting
  • Thymic Malignancies
  • Pleural Metastases
  • Intensity-Modulated Pleural Radiation Therapy (IMPRINT)
  • Basking Ridge, New Jersey
  • +6 more
May 2, 2022

Cancer Trial (single arm for all patients)

Not yet recruiting
  • Cancer
  • single arm for all patients
  • (no location specified)
Sep 26, 2022

NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Thymoma Trial in Shanghai (Radiotherapy Combined with GM-CSF)

Recruiting
  • Thymoma
  • Radiotherapy Combined with GM-CSF
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 2, 2022

Thymoma, Thymic Carcinoma, Clinical Masaoka Stage II to IVA Trial in United States (Cetuximab, Cisplatin, Doxorubicin &

Active, not recruiting
  • Thymoma
  • +2 more
  • Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
  • Duarte, California
  • +7 more
May 27, 2022

Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

Completed
  • Pancreas Cancer
  • +6 more
  • Rozzano, Milan, Italy
    Istituto Clinico Humanitas
Sep 9, 2022

Thymoma and Thymic Carcinoma Trial in Guangzhou (Thymosin a1, hypofractionated radiotherapy, concurrent chemoradiotherapy)

Active, not recruiting
  • Thymoma and Thymic Carcinoma
  • Thymosin a1
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Nov 27, 2021

Caregiver, Malignant Pleural Tumor, Metastatic Thymic Carcinoma Trial in Columbus (Palliative Therapy, Questionnaire

Completed
  • Caregiver
  • +11 more
  • Palliative Therapy
  • Questionnaire Administration
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 11, 2022

Thymoma Type B3, Thymic Carcinoma Trial in Worldwide (Nivolumab)

Recruiting
  • Thymoma Type B3
  • Thymic Carcinoma
  • Brussel, Belgium
  • +19 more
Jul 1, 2022

Cardiac MRI Biomarker Testing (GCC 1618)

Recruiting
  • Breast Cancer
  • +4 more
  • Complete Cardiac Magnetic Resonance Imaging (MRI)
  • Baltimore, Maryland
    Ummc Msgccc
Aug 16, 2021

Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

Not yet recruiting
  • Adrenal Cortical Carcinoma
  • +3 more
  • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023

Thymic Carcinoma, NSCLC, Refractory Thoracic Tumors Trial in United States (VEGFR/PDGFR Dual Kinase Inhibitor X-82, Nivolumab)

Active, not recruiting
  • Thymic Carcinoma
  • +3 more
  • VEGFR/PDGFR Dual Kinase Inhibitor X-82
  • Nivolumab
  • Palo Alto, California
  • +6 more
Sep 21, 2022

Cardiovascular Events Among Adults Relapsed or Refractory

Recruiting
  • Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
  • +9 more
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Type B3 Thymoma, Thymic Carcinoma Trial in Milan (Sunitinib)

Recruiting
  • Type B3 Thymoma
  • Thymic Carcinoma
  • Milan, Italy
    National Cancer Institute
Jun 8, 2021

Thymoma, Thymus Tumors Trial run by the NCI (Sunitinib)

Active, not recruiting
Has Results
  • Thymoma
  • Thymus Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 17, 2022

Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

Recruiting
  • Thyroid
  • +18 more
  • New Haven, Connecticut
  • +6 more
Apr 8, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent DLBCL, Recurrent High Grade B-Cell Lymphoma Trial in Houston (Anakinra,

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Anakinra
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2022

NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +10 more
  • Singapore, Singapore
    Novartis Investigative Site
Nov 16, 2022